Triumph Science&Technology Co Ltd
SSE:600552
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.58
15.29
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Triumph Science&Technology Co Ltd
Cash & Cash Equivalents
Triumph Science&Technology Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Triumph Science&Technology Co Ltd
SSE:600552
|
Cash & Cash Equivalents
¥352.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-3%
|
|
|
AVIC Jonhon Optronic Technology Co Ltd
SZSE:002179
|
Cash & Cash Equivalents
¥8.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
28%
|
CAGR 10-Years
25%
|
|
|
BOE Technology Group Co Ltd
SZSE:000725
|
Cash & Cash Equivalents
¥80.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Avary Holding Shenzhen Co Ltd
SZSE:002938
|
Cash & Cash Equivalents
¥10.4B
|
CAGR 3-Years
44%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Luxshare Precision Industry Co Ltd
SZSE:002475
|
Cash & Cash Equivalents
¥37.3B
|
CAGR 3-Years
38%
|
CAGR 5-Years
47%
|
CAGR 10-Years
46%
|
|
|
L
|
Lens Technology Co Ltd
SZSE:300433
|
Cash & Cash Equivalents
¥8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Triumph Science&Technology Co Ltd
Glance View
Triumph Science & Technology Co. Ltd. is a storied entity in the realm of advanced materials, rooted in its distinctive expertise in glass technology and engineering. Situated at the intersection of innovation and tradition, this company harnesses its extensive industry knowledge to transform silica, a humble mineral, into cutting-edge products that cater to global markets. Building on a rich legacy, Triumph spearheads the development of high-performance glass solutions, ranging from energy-efficient architectural glass to sophisticated electronic displays. Its operations are buttressed by a robust R&D framework, which fuels continuous improvements and keeps Triumph at the forefront of technological advancements. This relentless pursuit of excellence has established the company as a trusted partner to industries that demand precision and reliability. The financial engine of Triumph Science & Technology Co. Ltd. thrives on a diversified product portfolio tailored to different sectors' unique needs. The company generates revenue through large-scale collaborations with construction firms, technology companies, and green energy initiatives, which seek cutting-edge glass solutions to enhance their product offerings. These partnerships amplify Triumph's reach and reinforce its position in the competitive arena. Additionally, the company capitalizes on economies of scale, optimizing production processes to streamline costs and maximize profitability. Through a combination of strategic alliances and innovative product development, Triumph succeeds in adding durable value to its clients while simultaneously driving its financial success.
See Also
What is Triumph Science&Technology Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
352.9m
CNY
Based on the financial report for Sep 30, 2024, Triumph Science&Technology Co Ltd's Cash & Cash Equivalents amounts to 352.9m CNY.
What is Triumph Science&Technology Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-3%
Over the last year, the Cash & Cash Equivalents growth was -72%. The average annual Cash & Cash Equivalents growth rates for Triumph Science&Technology Co Ltd have been -19% over the past three years , -11% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet